世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

中南米の皮下注射器と針の市場規模、シェア、動向分析レポート タイプ別(針、注射器、コンビネーション)、地域別、セグメント別予測、2023年~2030年


Latin America Hypodermic Syringes And Needles Market Size, Share & Trends Analysis Report By Type (Needles, Syringes, Combination), By Region, And Segment Forecasts, 2023 - 2030

ラテンアメリカ 皮下注射器・注射針市場の成長と動向 中南米の皮下注射器と針の市場規模は、2030年には3億5,059万米ドルに達すると予測されています。2023年から2030年にかけての年平均成長率は5.7%で拡大する... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年1月6日 US$3,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
95 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ラテンアメリカ 皮下注射器・注射針市場の成長と動向

中南米の皮下注射器と針の市場規模は、2030年には3億5,059万米ドルに達すると予測されています。2023年から2030年にかけての年平均成長率は5.7%で拡大すると予測されています。集団予防接種プログラムの増加や、さまざまな慢性疾患に関する意識の高まりが、皮下注射器・針市場の需要を押し上げる要因となっています。

さらに、WHOや国連などの政府機関が、病気の感染を減らし、安全な薬物送達の実践に関する意識を高めるための取り組みを強化していることも、業界の成長につながると期待されています。これらの組織は、安全な薬物送達のためにいくつかのイニシアチブをとっています。これらの機関が実施するプログラムには、注射針と注射器のプログラム、性感染症の予防と治療、標的情報、注射薬使用者(IDU)とその性的パートナーに対する教育・コミュニケーションなどがあります。

COVID-19のパンデミックは、死亡率の低下やウイルス感染リスクのある患者の重症化を抑制するためのワクチン需要の増加により、市場に好影響を与えた。注射器と注射針の需要が急増し、多くの企業が生産能力を大幅に増強する必要がありました。COVID-19の新たな波が予想され、ブースター投与の導入に継続的に取り組む製薬会社が増えていることから、同市場は予測期間中も大きな成長を遂げると予想されます。

中南米の皮下注射器と注射針市場レポートハイライト

- 注射針と比較して普及率が高く、価格も高いため、2022年は注射器分野が市場を支配した

- インスリンを投与するためにこれらの製品の採用が増加していることから、2022年にはコンビネーション部門が2番目に高いシェアを占めています。

- ブラジルは、COVID-19の患者数が多く、他の国と比較して医療施設が充実していることから、2022年の市場シェアは最高となりました。

- 疾病の発生件数が増加していることから、ベネズエラは予測期間中に最大限の成長を遂げると予想される。



ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Latin America Hypodermic Syringes and Needles Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rise in the prevalence of diabetes, asthma, and other serious allergies
3.4.1.2. Increase in the number of initiatives by government organizations
3.4.1.3. Impact of Covid-19 pandemic.
3.4.2. Market restraint analysis
3.4.2.1. Frequent product recalls
3.4.2.2. Presence of alternatives
3.5. Latin America Hypodermic Syringes and Needles Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Latin America Hypodermic Syringes and Needles: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Needles
4.1.2. Syringes
4.1.3. Combination
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Latin America Hypodermic Syringes and Needles Market by Type Outlook
4.5. Market Product & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Needles
4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.2. 16-18G
4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.3. 19-21G
4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.4. 22-25G
4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.5. 26-29G
4.5.1.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.6. 30-32G
4.5.1.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2. Syringes
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.2. 1-5ml
4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.3. 5-10ml
4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.4. 11-15ml
4.5.2.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.5. 16-20ml
4.5.2.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.6. 21-25ml
4.5.2.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.7. 26-30ml
4.5.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.8. 31-35ml
4.5.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.9. 36-40ml
4.5.2.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.10. 41-45ml
4.5.2.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.11. 46-50ml
4.5.2.11.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3. Combination
4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Latin America Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. Latin America
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. Latin America
5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030:
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.2. Mexico
5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.3. Argentina
5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.4. Colombia
5.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.5. Chile
5.7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.6. Uruguay
5.7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.7. Venezuela
5.7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.8. Bolivia
5.7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.9. Peru
5.7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.10. Ecuador
5.7.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Cardinal Health Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Terumo Corporation
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BD
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Nipro Corporation
6.3.7.1. Overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B.Braun Melsungen
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Smiths Medical, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Lifelong Meditech Private Limited
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Exelint International, Co.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Vitrex Medical A/S
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Retractable Technologies, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Latin America Hypodermic Syringes and Needles Market Growth & Trends

The Latin America hypodermic syringes and needles market size is projected to reach USD 305.59 million by 2030. The market is anticipated to expand at a CAGR of 5.7% from 2023 to 2030. An increasing number of mass vaccination programs and rising awareness regarding various chronic conditions are factors boosting the demand for the hypodermic syringes and needles market.

Moreover, increasing efforts to reduce the transmission of diseases and create awareness regarding safe drug delivery practices by government organizations such as WHO and the UN are also expected to lead to the industry’s growth. These organizations have undertaken several initiatives for safe drug delivery. Some of the programs conducted by these organizations are needle & syringe programs; prevention & treatment of sexually transmitted infections; targeted information; and education & communication for Injecting Drug Users (IDUs) and their sexual partners.

The COVID-19 pandemic had a positive impact on the market due to the increasing demand for vaccines to reduce the mortality rate and to control the severity of the virus in patients with the risk of being infected with it. The demand for syringes and needles witnessed a tremendous upsurge and many companies had to increase their production capacities to a great extent. With new anticipated COVID-19 waves and an increasing number of pharmaceutical companies continuously working towards introducing booster doses, the market is further anticipated to experience significant growth over the forecast as well.

Latin America Hypodermic Syringes and Needles Market Report Highlights

• The syringes segment dominated the market in 2022 due to the increasing adoption rate and higher price as compared to needles

• The combination segment held the second-highest share in 2022 owing to the increasing adoption of these products to administer insulin

• Brazil held the highest market share in 2022 owing to the huge COVID-19 patient pool in the country, and better availability of healthcare facilities as compared to the other countries

• Due to the rising number of the outbreak of diseases, Venezuela is anticipated to experience maximum growth in the market over the forecast period



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Latin America Hypodermic Syringes and Needles Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rise in the prevalence of diabetes, asthma, and other serious allergies
3.4.1.2. Increase in the number of initiatives by government organizations
3.4.1.3. Impact of Covid-19 pandemic.
3.4.2. Market restraint analysis
3.4.2.1. Frequent product recalls
3.4.2.2. Presence of alternatives
3.5. Latin America Hypodermic Syringes and Needles Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Latin America Hypodermic Syringes and Needles: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Needles
4.1.2. Syringes
4.1.3. Combination
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Latin America Hypodermic Syringes and Needles Market by Type Outlook
4.5. Market Product & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Needles
4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.2. 16-18G
4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.3. 19-21G
4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.4. 22-25G
4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.5. 26-29G
4.5.1.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.1.6. 30-32G
4.5.1.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2. Syringes
4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.2. 1-5ml
4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.3. 5-10ml
4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.4. 11-15ml
4.5.2.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.5. 16-20ml
4.5.2.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.6. 21-25ml
4.5.2.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.7. 26-30ml
4.5.2.7.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.8. 31-35ml
4.5.2.8.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.9. 36-40ml
4.5.2.9.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.10. 41-45ml
4.5.2.10.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.2.11. 46-50ml
4.5.2.11.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
4.5.3. Combination
4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Latin America Hypodermic Syringes and Needles Market: Regional Estimates & Trend Analysis
5.1. Regional market share analysis, 2022 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Regional Market Share and Leading Players, 2022
5.4.1. Latin America
5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.5.1. Latin America
5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030:
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.2. Mexico
5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.3. Argentina
5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.4. Colombia
5.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.5. Chile
5.7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.6. Uruguay
5.7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.7. Venezuela
5.7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.8. Bolivia
5.7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.9. Peru
5.7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
5.7.10. Ecuador
5.7.10.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2022
6.3.4. Cardinal Health Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Terumo Corporation
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. BD
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Nipro Corporation
6.3.7.1. Overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. B.Braun Melsungen
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Smiths Medical, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Lifelong Meditech Private Limited
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Exelint International, Co.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Vitrex Medical A/S
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Retractable Technologies, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る